World Coronavirus Dispatch: Israel shows what return to office looks like

Israel shows the world what return to office will look like

Helped by one of the fastest vaccination drives in the world, Israel has more or less reopened its economy and nearly two months after doing so, it is moving on from the work-from-home era, something the world is keeping a close eye on. Employers and employees around the world are watching with interest to see what happens in a country that has come to be seen as a late-pandemic bellwether and how the life after coronavirus looks like. Israel offers a glimpse for other economic hubs of what work may look like soon, as workers and employees alike seek to rekindle the sense of community they lost last year.

Let's look at the global statistics

Global infections: 155,216,499

Global deaths: 3,242,360

Nations with most cases: US (32,557,606), India (21,077,410), Brazil (14,930,183), France (5,767,541), Turkey (4,955,594).


Biden backs suspending patents on vaccines

Amid criticism for not doing enough as the world leader, Biden has set out to take, what he calls, some extraordinary steps to help the world tide over the coronavirus crisis. In line with this, Biden administration said it backs waiving intellectual property rights for vaccines against the deadly coronavirus disease at the World Trade Organization (WHO). The proposal if cleared, could allow drugmakers across the globe access to the closely guarded trade secrets of how the viable vaccines have been made. This comes in the wake of raging inequality in access to vaccines between the developed and developing nations, especially among the poor countries.

Pfizer vaccine is effective against severe disease caused by two variants, finds study

Studies based on real-world data from Israel and Qatar suggest the Pfizer-BioNtech vaccine is extremely effective against the severe disease caused by two variants, found in UK and South Africa. Earlier reaearch showed vaccines appeared to be less effective against B.1.351 (South African Variant). The katest study, which appeared in the New England Journal of Medicine, is based on information about more than 200,000 people from Qatar’s national Covid-19 databases between February 1 and March 31. The researchers found that the vaccine was 97.4 percent effective at preventing severe, critical or fatal disease from any form of the coronavirus, and 100 percent effective at preventing severe, critical or fatal disease caused by both UK and South African Variants.

Speed production of vaccines or Covid won’t go until 2024: French minister at G7 meeting

Vaccine production should be ramped up on a warp speed and more needed to be done to ensure they were reaching the world’s poorest people, and the G7 had a responsibility to do more, the French foreign minister said as he attended the G7 meeting. He said the coronavirus will continue to wreak havoc across the world till 2024 unless the G7 focuses on increasing vaccine production. “If we continue at this pace … then there will not be global immunity until 2024. Are we going to wait until 2024 keeping on with our masks, our tests, our constraints and our fears? I do not think that is a solution for us or the world," he said.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel